Isotretinoin works through several overlapping biological mechanisms rather than a single on-off switch. Once inside the body, the drug shrinks oil-producing glands, triggers programmed death of the cells lining those glands, dials down inflammation, and shifts the bacterial community living in skin pores. What makes isotretinoin unusual among acne treatments is that these effects often persist long after the course ends, which is why researchers have spent decades trying to untangle exactly how a single molecule can reshape so many processes at once.
What Happens to the Drug Inside Your Cells
Isotretinoin’s chemical name is 13-cis retinoic acid, and for years there was a puzzle: it binds poorly to the receptors that other retinoids use to change gene activity. The answer turned out to be that isotretinoin doesn’t do most of the heavy lifting in its original form. Once it enters sebocytes, the oil-producing cells of the sebaceous gland, it gets converted into all-trans retinoic acid, which binds tightly to retinoid acid receptors and flips on a cascade of gene changes.1PubMed. 13-cis retinoic acid exerts its specific activity on human sebocytes through selective intracellular isomerization to all-trans retinoic acid and binding to retinoid acid receptors Think of isotretinoin as a prodrug, a delivery vehicle that gets reshaped into its active form right where it’s needed.
Early research showed that cellular retinoic acid-binding proteins in both skin and sebaceous follicles have a much weaker grip on 13-cis retinoic acid than on all-trans retinoic acid. In sebaceous follicle tissue the binding affinity was roughly nine times weaker, and in the surrounding skin it was about 30 times weaker.2PubMed. Cellular retinoic acid-binding proteins in human epidermis and sebaceous follicles That mismatch is actually part of why the intracellular conversion step matters so much. The drug arrives in a form that sidesteps the skin’s usual binding proteins, gets inside the cell, and only then transforms into the potent version that activates retinoid receptors.
Crushing Sebum Production
The most dramatic measurable effect of isotretinoin is a steep drop in sebum, the oily mixture that sebaceous glands secrete into hair follicles. In one classic study, 16 weeks of treatment produced roughly an 88% decrease in sebum output alongside a visible shrinkage of the glands themselves, though gland activity partially recovered by 32 weeks after stopping the drug.3JAMA Dermatology. Isotretinoin in the Treatment of Acne: Histologic Changes, Sebum Production, and Clinical Observations Even low doses have a meaningful impact. A trial using very small daily doses found sebum production dropped by up to about 64%, with biopsies showing gland size shrank by roughly half.4PubMed. Very low dose isotretinoin is effective in controlling seborrhea
This sebum suppression is central to why isotretinoin works against acne. Excess sebum creates an environment where pores become clogged and bacteria thrive. By starving follicles of their oily fuel, isotretinoin attacks the root conditions that allow acne to develop. The low-dose study also noticed a shift in the composition of remaining lipids, with triglycerides becoming the dominant fraction rather than the usual mix, suggesting the drug doesn’t just reduce oil quantity but changes its character.5PubMed. Very low dose isotretinoin is effective in controlling seborrhea
How Sebocytes Die Off
Shrinking sebaceous glands isn’t just about producing less oil per cell. Isotretinoin actively causes sebocytes to self-destruct through apoptosis, a controlled form of cell death. The drug triggers the production of several pro-apoptotic proteins, including TRAIL (tumor necrosis factor-related apoptosis-inducing ligand), insulin-like growth factor-binding protein-3, and neutrophil gelatinase-associated lipocalin.6PubMed. Apoptosis May Explain the Pharmacological Mode of Action and Adverse Effects of Isotretinoin, Including Teratogenicity TRAIL appears to be a particularly important player. When researchers used gene-silencing techniques to block TRAIL production in sebocytes exposed to isotretinoin, the percentage of dying cells dropped roughly threefold, from about 25% to about 8%.7PubMed Central. TRAIL contributes to the apoptotic effect of 13-cis retinoic acid in human sebaceous gland cells
This apoptotic mechanism is important beyond just explaining clear skin. The same researchers who mapped these pathways have proposed that the apoptotic action of isotretinoin also explains its most notorious side effect: teratogenicity, the ability to cause severe birth defects. The thinking is that isotretinoin’s apoptosis-triggering machinery doesn’t limit itself to sebocytes. In a developing embryo, the same signals can cause cell death in tissues that are actively forming, leading to craniofacial, cardiovascular, and neurological malformations. Estimates put the risk of birth defects for pregnancies exposed to isotretinoin at roughly 20 to 35%.8PubMed Central. Teratogenic effect of isotretinoin in both fertile females and males (Review) The connection between the drug’s therapeutic action and its most dangerous side effect runs through the same molecular process.
The FoxO Transcription Factor Hypothesis
One of the more compelling recent frameworks for understanding isotretinoin links many of its effects to a family of proteins called FoxO transcription factors, particularly FoxO1 and FoxO3. These proteins act as master regulators inside cells, influencing everything from whether a cell divides to whether it commits to apoptosis, how it handles lipids, and how it responds to hormones like insulin and androgens.9PubMed Central. Isotretinoin and FoxO1: A scientific hypothesis
The hypothesis proposes that isotretinoin’s main job, at the gene-regulation level, is to push FoxO proteins into the cell nucleus where they’re active. A study of acne patients taking isotretinoin confirmed this in living human tissue: treatment produced a significant increase in the nuclear-to-cytoplasmic ratio of both FoxO1 and FoxO3 in sebaceous glands.10PubMed. Effect of oral isotretinoin on the nucleo-cytoplasmic distribution of FoxO1 and FoxO3 proteins in sebaceous glands of patients with acne vulgaris When FoxO proteins are active in the nucleus, they dampen androgen receptor signaling (androgens are a major driver of sebum production), inhibit the lipid-making pathways that sebocytes rely on, and push cells toward apoptosis. This single upstream shift could explain why isotretinoin affects so many different processes simultaneously.
The FoxO framework also offers a potential explanation for isotretinoin’s chemopreventive effects and even some of its adverse reactions. FoxO proteins influence stem cell maintenance, immune regulation, and oxidative stress handling, all of which line up with observed effects of the drug. Researchers have described this as “substantial indirect evidence,” meaning the pieces fit together logically even though a direct causal chain hasn’t been fully proven in every tissue type.11PubMed Central. Isotretinoin and FoxO1: A scientific hypothesis
Quieting Inflammation
Acne is fundamentally an inflammatory condition, not just a cosmetic one, and isotretinoin has direct anti-inflammatory effects that go beyond simply removing sebum and bacteria. A key study tracked what happens to immune cells in acne patients during and after treatment. Isotretinoin significantly reduced the expression of TLR-2, a receptor on immune cells that recognizes bacterial components and triggers inflammatory cascades. In practical terms, patients’ immune cells became much less reactive to the acne-causing bacterium Cutibacterium acnes. Production of several inflammatory signaling molecules dropped, including IL-1β, IL-6, IL-10, and IL-12p70.12PubMed Central. Systemic isotretinoin therapy normalizes exaggerated TLR-2-mediated innate immune responses in acne patients
What makes this finding especially interesting is the timeline. The reduction in inflammatory signaling started within just one week of beginning treatment, continued to deepen through 20 weeks, and was still present six months after the drug was stopped.13PubMed Central. Systemic isotretinoin therapy normalizes exaggerated TLR-2-mediated innate immune responses in acne patients That sustained immune recalibration likely explains a lot about why isotretinoin’s effects outlast the treatment course itself. The drug doesn’t just suppress acne while you’re taking it; it resets the immune system’s baseline reactivity to skin bacteria.
Reshaping the Skin Microbiome
For decades, the assumption was that isotretinoin simply killed off C. acnes by depriving it of the sebum-rich environment it depends on. The reality is more nuanced. Rather than eliminating the bacterium entirely, isotretinoin reshapes which strains dominate. Research tracking the follicular microbiome during treatment found that successful clinical responses correlated with increased diversity among C. acnes strains, particularly in certain strain clusters. Patients who responded well to treatment showed a broader community of bacterial strains by week 20, along with reduced expression of genes tied to four metabolic pathways that support bacterial growth and survival.14PubMed Central. Treatment response to isotretinoin correlates with specific shifts in Cutibacterium acnes strain composition within the follicular microbiome
This is a subtler picture than “drug kills bacteria.” The treatment seems to dismantle the dominance of aggressive strain types and promote a more balanced microbial ecosystem within the follicle. It’s consistent with what we know about sebum suppression: take away the preferred food source and the competitive landscape changes, favoring strains that are less inflammation-provoking. Whether the microbiome shift is a cause of improvement or a consequence of it remains an area of active investigation, but the correlation between strain diversity and clinical clearing is strong.
Tissue Remodeling and Matrix Effects
Severe acne often leaves scars because the inflammatory process damages the structural scaffolding of the skin. Isotretinoin appears to influence this process through matrix metalloproteinases (MMPs), enzymes that break down collagen and other structural proteins. Sebum from acne patients contains proMMP-9, and isotretinoin treatment, whether oral or topical, reduced proMMP-9 levels in parallel with clinical improvement. In laboratory studies, the drug also inhibited both the production and gene expression of proMMP-2, proMMP-9, and MMP-13 in skin cells.15PubMed. Matrix metalloproteinases of epithelial origin in facial sebum of patients with acne and their regulation by isotretinoin
By dialing down these tissue-destroying enzymes, isotretinoin may limit the collateral damage that inflamed follicles cause to surrounding skin. This is a less-discussed aspect of the drug’s action but a relevant one for patients with cystic or nodular acne where scarring is a primary concern.
Why Isotretinoin Dries Out Everything
The most common complaint during an isotretinoin course is dryness: chapped lips, dry eyes, flaking skin, nosebleeds. These aren’t random side effects; they flow directly from the drug’s mechanism. Isotretinoin alters the skin’s barrier function by suppressing the sebaceous lipids that normally keep the surface hydrated and protected. The result is impaired water retention, reduced antimicrobial defense at the skin surface, and a weakened antioxidant barrier.16PubMed Central. Challenges and Solutions in Oral Isotretinoin in Acne: Reflections on 35 Years of Experience The lips are hit hardest because they have a dense concentration of sebaceous glands and no sweat glands to compensate. Mucosal surfaces throughout the body, from nasal passages to the conjunctiva of the eyes, are affected for the same reason.
Understanding that these effects are a direct extension of sebum suppression, not an unrelated toxicity, is useful. It means the dryness is actually a sign the drug is working as intended. It also means that aggressive moisturizing and barrier-repair strategies are the appropriate management approach, not a reason to question whether the medication is causing harm.
Metabolic Side Effects and Lipid Changes
Routine blood monitoring during isotretinoin treatment typically tracks liver enzymes and lipid levels, and for good reason. Isotretinoin can raise triglycerides and alter cholesterol profiles. The mechanism appears to involve increased expression of apolipoprotein C-III in liver cells, a protein that slows the clearance of triglyceride-rich particles from the bloodstream.17PubMed Central. The Impact of Isotretinoin on Lipid Profile: a Systematic Review For most patients the changes are modest and reversible after treatment ends, but for people with pre-existing lipid disorders or genetic predispositions to high triglycerides, the shifts can be clinically meaningful. This is why blood work at regular intervals isn’t just a formality.
Effects on the Brain
The question of whether isotretinoin causes depression has been debated for decades, and the mechanism-of-action research sheds some light on why the concern persists even when large epidemiological studies have produced mixed results. The drug has measurable effects on neurotransmitter systems. Animal studies have shown that isotretinoin can reduce serotonin neurons in the brainstem, decrease serotonin transporters and receptors in the hippocampus, and disrupt connections between serotonin-producing brain regions and areas involved in memory and emotion.18PubMed Central. Isotretinoin and neuropsychiatric side effects: Continued vigilance is needed It also influences dopamine signaling in reward-related brain circuits, and mice engineered with mutations in retinoid receptors show behaviors consistent with dopamine deficits.19PubMed Central. Isotretinoin and neuropsychiatric side effects: Continued vigilance is needed
These findings establish that isotretinoin has the biological plumbing to affect mood, even if the clinical evidence for a strong causal link in humans remains contested. The proposed pathway is that the drug’s retinoid activity alters adult neurogenesis in the hippocampus and impairs serotonin signaling, both of which are implicated in depression.20PubMed. Retinoid-mediated regulation of mood: possible cellular mechanisms The hippocampal effects also raise questions about cognition and memory during treatment, a complaint some patients report anecdotally but that has received less formal study.
How the Body Clears Retinoic Acid
Individual variation in response to isotretinoin, why some people clear acne quickly while others need longer courses, or why side effects hit some patients harder, may partly come down to how efficiently a person metabolizes retinoic acid. A family of enzymes called CYP26, particularly CYP26A1, are the primary enzymes responsible for breaking down retinoic acid inside cells. These enzymes are also induced by retinoic acid itself, creating a feedback loop: the more active retinoid present, the faster the body tries to clear it. Preliminary data suggest that even low expression levels of CYP26A1 in the liver could make it the dominant retinoic acid-clearing enzyme in that tissue.21Expert Opinion on Drug Metabolism & Toxicology. The role of CYP26 enzymes in retinoic acid clearance
Genetic variation in CYP26 enzyme activity could explain why two patients on the same dose have very different drug levels and very different experiences. Someone with highly active CYP26 enzymes would clear isotretinoin faster, potentially needing higher or longer dosing. Someone with sluggish CYP26 activity might accumulate more retinoic acid in tissues, experiencing stronger effects and more side effects at standard doses. Pharmacogenomic testing for these enzymes isn’t yet part of routine clinical practice, but the logic is there for why it might eventually be useful.
Sebaceous Gland Homeostasis and Why Acne Can Return
If isotretinoin shrinks sebaceous glands and kills off their cells, why does acne sometimes come back after a full course? The answer lies in how sebaceous glands regenerate. These glands are maintained by stem and progenitor cells that reside in the follicular niche, and the gland’s long-term behavior is governed by a web of hormonal and signaling inputs including androgens, insulin and insulin-like growth factor-1, retinoid signaling, and the Wnt pathway.22British Journal of Dermatology. Homeostasis of the sebaceous gland and mechanisms of acne pathogenesis Isotretinoin disrupts several of these inputs during treatment, but it does not permanently eliminate the stem cells. Once drug levels drop, those progenitor cells can slowly rebuild the gland.
For most patients, the glands recover to a more moderate state of activity, one that produces enough sebum for normal skin function without tipping back into the overproduction that fuels acne. But in a subset of patients, particularly those with strong hormonal drivers or who were treated with lower cumulative doses, the glands may eventually return to their pre-treatment state. This is why dermatologists track cumulative dosing and why some patients end up needing a second course years later. The drug’s long-lasting effects on immune reactivity and the follicular microbiome likely play a role in extending remission beyond what sebum suppression alone would predict, but gland regeneration remains the key variable in relapse.